Graft-versus-host disease (GVHD) is a major factor contributing to mortality and morbidity
after allogeneic stem-cell transplantation. Because of the small number of results from well …

Patients with severe aplastic anemia (SAA) can be successfully treated with bone marrow
transplantation (BMT) or immunosuppressive therapy (IS). The current outcome using both …

An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and …

Background Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis
are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of …

Background Nephropathy associated with the polyomavirus type BK (BKV) nephropathy has
emerged as a cause of allograft failure linked to immunosuppressive regimens containing …

Background The late effects of bone marrow transplantation, including cancer, need to be
determined in a large population at risk. Methods We studied 19,229 patients who received …

Acute graft‐versus‐host disease (GVHD) severity is graded by pattern of organ involvement
and clinical performance status using a system introduced by Glucksberg and colleagues 21 …

Background and Methods It is uncertain whether mortality rates among patients who have
undergone bone marrow transplantation return to the level of the mortality rates of the general …

Background Patients with acute myeloid leukemia (AML) often reach complete remission, but
relapse rates remain high. Next-generation sequencing enables the detection of molecular …

Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by aberrant
hematopoietic proliferation and an increased tendency toward leukemic transformation. …